SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009375
Filing Date
2017-05-08
Accepted
2017-05-08 16:03:35
Documents
46
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q derm-10q_20170331.htm 10-Q 1611672
2 EX-31.1 derm-ex311_8.htm EX-31.1 16920
3 EX-31.2 derm-ex312_7.htm EX-31.2 17573
4 EX-32.1 derm-ex321_9.htm EX-32.1 5759
5 EX-32.2 derm-ex322_6.htm EX-32.2 6415
  Complete submission text file 0001564590-17-009375.txt   4686504

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT derm-20170331.xml EX-101.INS 985053
7 XBRL TAXONOMY EXTENSION SCHEMA derm-20170331.xsd EX-101.SCH 28036
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE derm-20170331_cal.xml EX-101.CAL 32064
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE derm-20170331_def.xml EX-101.DEF 72448
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE derm-20170331_lab.xml EX-101.LAB 222265
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE derm-20170331_pre.xml EX-101.PRE 163028
Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Filer) CIK: 0001557883 (see all company filings)

IRS No.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36668 | Film No.: 17822195
SIC: 2834 Pharmaceutical Preparations